MedPath

Evaluation of Health Related Quality of Life among Reproductive Age Group Women in Poly Cystic Ovarian Syndrome patients-A Cross Sectional Study

Not yet recruiting
Conditions
Polycystic ovarian syndrome,
Registration Number
CTRI/2020/04/024922
Lead Sponsor
Government Siddha Medical College
Brief Summary

It is a cross sectional study to evaluate the health related quality of life  among  reproductive age group  between  15 to 35 years attending out patient department at Arignar  Anna  Govt Hospital of Indian medicine , Chennai . The questionnaire which consists of 33 questions to assess the symptoms of poly cystic ovarian syndrome. That the results obtained will  identify the physical and emotional aspects of the patients affected with poly cystic ovarian syndrome to proceed for an effective treatment

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Female
Target Recruitment
100
Inclusion Criteria

Female patients age between 15 to 35 years attending out patient department at Arignar Anna Govt Hospital of Indian Medicine.

Exclusion Criteria

Age group less than 15 years and above 35 years.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The present study will evaluate the health related quality of life in soothaga vaayu (poly cystic ovarian syndrome) among reproductive age group of women by HRQL .12 weeks
Secondary Outcome Measures
NameTimeMethod
Assessment of HRQL will give information about physical and emotional aspect of PCOS patients for giving effective treatment related to them in future clinical trials12 weeks

Trial Locations

Locations (1)

Arignar Anna Government Hospital of Indian Medicine

🇮🇳

Chennai, TAMIL NADU, India

Arignar Anna Government Hospital of Indian Medicine
🇮🇳Chennai, TAMIL NADU, India
Dr Boomathi S
Principal investigator
9095909539
boomathisozhanambi@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.